Drug recall · October 5, 2016
PREMARIN recall
Why: Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91
- Lots / codes
Lot # M35953S; Exp. 11/17 (labeled).
- Quantity
- 1,316 bottles (1,316,000 tablets)
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide
- Initiated
- September 15, 2016 · Voluntary: Firm initiated
- Classified
- September 27, 2016
- Reported
- October 5, 2016
- Ended
- August 9, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Premarin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.